posted on 2013-12-06, 00:00authored byNoor Akhter, Angela K. Odle, Melody L. Allensworth-James, Anessa C. Haney, Mohsin M. Syed, Michael A. Cozart, Streamson Chua, Rhonda Kineman, Gwen V. Childs
Mice with somatotrope-specific deletion of the Janus kinase binding site in leptin receptors are GH
deficient as young adults and become obese by 6 months of age. This study focused on the metabolic
status of young (3– 4.5 month old) preobese mutant mice. These mutants had normal body
weights, lean body mass, serum leptin, glucose, and triglycerides. Mutant males and females
showed significantly higher respiratory quotients (RQ) and lower energy output, resulting from a
higher volume ofCO2 output and lower volume ofO2 consumption. Deletion mutant females were
significantly less active than controls; they had higher levels of total serum ghrelin and ate more
food. Mutant females also had lower serum insulin and higher glucagon. In contrast, deletion
mutant males were not hyperphagic, but they were more active and spent less time sleeping.
Adiponectin and resistin, both products of adipocytes, were increased in male and female mutant
mice. In addition, mutant males showed an increase in circulating levels of the potent lipogenic
hormone, glucose-dependent insulinotropic peptide. Taken together, these results indicate that
mutant mice may become obese due to a reduction in lipid oxidation and energy expenditure. This
may stem from GH deficiency. Reduced fat oxidation and enhanced insulin sensitivity (in females)
are directly related to GH deficiency in mutant mice because GH has been shown by others to
increase insulin sensitivity and fat oxidation and reduce carbohydrate oxidation. Gender-dependent
alterations in metabolic signals may further exacerbate the future obese phenotype and
affect the timing of its onset. Females show a delay in onset of obesity, perhaps because of their
low serum insulin, which is lipogenic, whereas young males already have higher levels of the
lipogenic hormone, glucose-dependent insulinotropic peptide. These findings signify that leptin
signals to somatotropes are vital for the normal metabolic activity needed to optimize body
composition.
Funding
This work was supported by Grants National Institutes of
Health (NIH) R03 HD059066 and NIH 1R01HD059056 (to
G.V.C.) and core facilities funded by NIH Grants NCRR P20
RR020146 and NIH P30 NS047546 (at University of Arkansas
for Medical Sciences), and NIH Grant P01 DK26687 (to S.C.),
Department of Veterans Affairs, Office of Research and Development,
Veterans Administration Merit Awards BX001114 and
NIH grant RO1 DK088133 (to R.D.K.).
History
Publisher Statement
The original version is available through Endocrine Society at DOI: 10.1210/en.2012-1331.
Citation
Akhter, N. Odle, A. K. Allensworth-James, M. L. Haney, A. C. Syed, M. M. Cozart, M. A. Chua, S. Kineman, R. Childs, G. V. Ablation of Leptin Signaling to Somatotropes: Changes in Metabolic Factors that Cause Obesity. Endocrinology. Aug 3 2012. doi: 10.1210/en.2012-1331